Direkt zum Inhalt
Merck
  • Reduction of lipid peroxidation products and advanced glycation end-product precursors by cyanobacterial aldo-keto reductase AKR3G1—a founding member of the AKR3G subfamily.

Reduction of lipid peroxidation products and advanced glycation end-product precursors by cyanobacterial aldo-keto reductase AKR3G1—a founding member of the AKR3G subfamily.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2014-11-08)
Jan Hintzpeter, Hans-Joerg Martin, Edmund Maser
ZUSAMMENFASSUNG

The purpose of this study was to investigate the origin and function of the aldo-keto reductase (AKR) superfamily as enzymes involved in the detoxification of xenobiotics. We used the cyanobacterium Synechocystis sp. PCC 6803 as a model organism and sequence alignments to find bacterial AKRs with highest identity to human enzymes. Disappearance of NADPH was monitored spectrophotometrically to calculate enzymatic activity. The molecular weight of the native protein was determined by size exclusion chromatography. Substrate docking was performed by SwissDock. Sequence alignments identified the NADPH-dependent AKR3G1 having 41.5 and 40% identity with the human enzymes AKR1B1 and AKR1B10, respectively. Highest enzymatic efficiency was observed with 4-oxonon-2-enal (4-ONE; k(cat)/K(m), 561 s(-1) mM(-1)) and 4-hydroxynonenal (k(cat)/K(m), 26.5 s(-1) mM(-1)), respectively. P74308 is the most efficient enzyme for 4-ONE discovered until now. Cooperativity of this monomeric enzyme was observed with some substrates. Enzyme inactivation or oligomerization as possible explanations for nonhyperbolic enzyme kinetics were ruled out by Selwyn's test and gel filtration. The role of the little investigated carbonyl-reducing enzymes in detoxification seems to be in fact a very old process with rarely observed nonhyperbolic enzyme kinetics as an adaptation mechanism to higher concentrations of reactive oxygen species.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
5-(Hydroxymethyl)furfural, ≥99%, FG
Sigma-Aldrich
Indomethacin, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
5-Hydroxymethyl-2-furaldehyd, 99%
Sigma-Aldrich
Zimtaldehyd, natural, ≥95%, FG
Sigma-Aldrich
Capronaldehyd, 98%
Sigma-Aldrich
Methylglyoxal -Lösung, ~40% in H2O
Sigma-Aldrich
Kumarin, ≥99% (HPLC)
Sigma-Aldrich
4-Nitro-benzaldehyd, 98% (GC)
Sigma-Aldrich
trans--Zimtaldehyd, 97%
Sigma-Aldrich
DL-Glyceraldehyd, ≥90% (GC)
Sigma-Aldrich
Carbenicillin, Ready Made Solution, 100 mg/mL in ethanol/water, 0.2 μm filtered
Sigma-Aldrich
4-Pyridincarboxaldehyd, 97%
Sigma-Aldrich
Glyoxal -Lösung, for molecular biology, BioReagent, ~40% in H2O (~8.8 M)
Sigma-Aldrich
2-Furaldehyd, ≥98%, FCC, FG
Sigma-Aldrich
Butyraldehyd, purified by redistillation, ≥99.5%
Sigma-Aldrich
trans--Zimtaldehyd, ≥99%
Sigma-Aldrich
Crotonaldehyd, vorwiegend trans, ≥99%, contains 0.1-0.2% BHT as stabilizer, 1% H2O as stabilizer
Sigma-Aldrich
trans--Zimtaldehyd, FCC, FG
Sigma-Aldrich
Crotonaldehyd (cis+trans), ratio of cis- and trans-isomers (~1:20), ≥99.5% (GC)
Sigma-Aldrich
Glyoxal -Lösung, 40 wt. % in H2O
Sigma-Aldrich
trans-2-Hexen-1-al, 98%
Sigma-Aldrich
2-Furaldehyd, 99%
Sigma-Aldrich
Indomethacin, meets USP testing specifications
Sigma-Aldrich
Butyraldehyd, ≥96.0%
Supelco
5-(Hydroxymethyl)-furfural, analytical standard
Sigma-Aldrich
2-Furaldehyd, natural, ≥98%, FCC, FG
Sigma-Aldrich
Methylglyoxal -Lösung, 40 wt. % in H2O
Sigma-Aldrich
trans-2-Hexen-1-al, ≥95%, FCC, FG
Sigma-Aldrich
Capronaldehyd, ≥97%, FCC, FG
Sigma-Aldrich
Capronaldehyd, natural, ≥95%, FG